Position in SRZN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,019,393
New position
Shares Held
39,283
first reported quarter
Ownership
0.338%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ellsworth Advisors, LLC holds $8,015,438 across 7 Biotechnology names. SRZN ranks #6 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYRE |
Spyre Therapeutics, Inc.
|
16,553 | $1,469,575 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
10,728 | $1,255,926 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
3,268 | $1,214,617 | |
| 4 | CYTK |
Cytokinetics Inc
|
12,858 | $1,095,373 | |
| 5 | RAPP |
Rapport Therapeutics, Inc.
|
24,539 | $1,022,540 | |
| 6 | SRZN |
Surrozen, Inc./DE
This page
|
39,283 | $1,019,393 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
27,001 | $938,014 |
All Filings in SRZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,019,393 | 39,283 | Shares | Sole | 2026-07-16 | |
| No filing history on record for this holder in this stock. | ||||||